31.03.2017

VivoSensMedical and Exeltis Germany sign exclusive distribution cooperation for OvulaRing

VivoSensMedical GmbH, a young start-up company supported by our SMILE Initiative (Self Management Initiative Leipzig) and Exeltis Germany GmbH have signed an exclusive distribution agreement for OvulaRing in Germany.

With its extensive external service, Exeltis Germany GmbH will distribute the OvulaRing from May 2017 to gynecologists and also advertises the product in women with children's needs. The goal is to establish OvulaRing as the standard tool in cycle diagnostics.

VivoSensMedical GmbH is a young, medical company from Leipzig which combines medical-scientific experience, technical know-how, marketing and sales expertise, and management practice. The company's vision is to transfer a wealth of experience of over 40 years of scientific work in clinical and user-friendly products to benefit both patients and doctors. VivoSensMedical strives to set new standards in diagnosis and treatment in the fields of gynaecology, reproductive and sexual medicine, and immunology and autoimmune diseases.

More Information (in German)

News

06.12.2018

Apply now: Shanghai Start-up Class 2019 *2nd Batch

DC-Hub supports German Start-ups and SMEs to build up a China competency. The program will pay for the 2019 class´s winners return flights, co-working seats in Shanghai, access to the DC-Hub network, events, and workshops. The...[more]

20.11.2018

Congratulations to the winners of our 2018 Leipzig Founder's Night

The goal of Leipzig Founder's Night is to award innovative ideas and growth-oriented startup business within the region of Leipzig. The target group of our competition includes students, scientists, entrepreneurs and businesses....[more]

12.11.2018

Inaugural lecture of the Guest Professor Dr. Amar Iqbal Anwar on 19.11.18

Spillover Effects of FDI in Africa: BRICS versus Developed Countries Compared to multinational corporations (MNCs) from advanced countries, emerging countries firms may have a comparative advantage when operating in developing...[more]